Experienced orthopedic surgeon from the Hospital for Special Surgery, innovator and former Chief Medical Technology Advisor joins company in an elevated capacity WARSAW, Ind., April 7, 2026 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Jonathan M.
Aberdeen Group plc reduced its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 3.9% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 167,309 shares of the medical equipment provider's stock after selling 6,740 shares during
SNDL (NASDAQ: SNDL - Get Free Report) and Zimmer Biomet (NYSE: ZBH - Get Free Report) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, dividends, valuation, risk, analyst recommendations, earnings and profitability. Risk and Volatility SNDL has a beta of 0.81,
First Community Trust NA lowered its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 77.0% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 2,107 shares of the medical equipment provider's stock after selling 7,050 shares during the period. First Community Trust NA's
Zimmer Biomet Holdings, Inc. (NYSE: ZBH - Get Free Report) has been given a consensus rating of "Hold" by the twenty-two research firms that are presently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating, seven have given a buy rating and
SG Americas Securities LLC grew its position in shares of Zimmer Biomet Holdings, Inc. (NYSE: ZBH) by 69.3% in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 103,462 shares of the medical equipment provider's stock after purchasing an
ZBH leans on knee growth, robotics innovation and steady markets, but debt levels and stiff competition complicate its near-term investment appeal.
Pre-Market Stock Futures: Futures are trading higher after President Trump signalled that talks with Iran are progressing positively, as we get ready to start another trading week, with the same issues that have dragged the stock market down for four consecutive weeks still in place. While we have had a virtual March Madness in stocks,... Here Are Monday's Top Wall Street Analyst Research Calls: APA Corporation, Cheniere Energy, Crown Castle, Hut 8, MongoDB, Red Rock Resorts, Super Micro Computer, Terawulf, and More.
Capricor Therapeutics (NASDAQ: CAPR - Get Free Report) and Zimmer Biomet (NYSE: ZBH - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership. Profitability This table compares Capricor Therapeutics and Zimmer
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
